These data indicate that CCL2 intramuscular injection mimics some but not all features of a CCL2-expressing mammary tumor model, and that additional 4T1 tumor-derived factors could affect the expression of MYH and MYL in muscle. This evidence concerns the gene CCL2 and neoplasm.